Seeking Alpha


Send Message
View as an RSS Feed
View fdattny's Comments BY TICKER:

Latest comments  |  Highest rated
  • Amarin (AMRN -3.2%) says the USPTO has published a Notification of Patent Allowance for claims intended to protect the Vascepa indication approved by the FDA based on its Marine clinical trial results. The claim covers use of highly pure icosapent ethyl, including Vascepa, in lowering triglycerides regardless of the drug's effect on LDL-C levels. AMRN plans to list this patent in the FDA's Orange Book. [View news story]
    It's ALL about the patents- this is the winner!
    Dec 13, 2012. 02:45 PM | Likes Like |Link to Comment
  • Amarin Corporation Drops A Double Dose Of Bad News [View article]
    I take issue with this article stating that insiders were selling aggressively before the drug launch, implying the management does not have faith in their company. The shares sold appear to be automatic selling as options came due, plus normal VC cash out of investor positions.
    Dec 7, 2012. 06:42 AM | 4 Likes Like |Link to Comment